Michael E. Williams, MD, ScM
Byrd S. Leavell Professor of Medicine and Professor of Pathology; Chief, Hematology/Oncology Division; University of Virginia Health System, Charlottesville, VA, USA
Dr. Williams received his MD from the University of Cincinnati College of Medicine and a Master of Science from the Harvard School of Public Health. He completed his Medicine residency, Chief Residency, and Fellowship in Hematology/Oncology at the University of Virginia Health System in Charlottesville, where he currently serves as Chief of the Hematology/Oncology Division.
Dr. Williams’ research interests are in novel therapeutic approaches for non-Hodgkin lymphoma and CLL, including targeted agents and immuno-therapeutics. He serves on the Scientific Advisory Board Executive Committee of the Lymphoma Research Foundation, is vice-chair of the Eastern Cooperative Oncology Group Lymphoma Core Committee, and is a member of the European Mantle Cell Lymphoma Network.
Dr. Williams is past Chair of the Hematology Subspecialty Board of the American Board of Internal Medicine, and a former ABIM Council Member. He participates regularly in national and international programs devoted to education and research in lymphoma and CLL.